Immunic AG | WebDisclosure

Basculer en Français

9478	Companies
185484	Keywords
117839	Articles
99329	Press releases

Home
Companies
Immunic AG

BRIEF

published on 01/07/2025 at 12:35, 10 months 29 days ago

Immunic's 2024 Achievements and Future Prospects

Clinical Trials Multiple Sclerosis Vidofludimus Calcium 2024 Milestones Immunic AG
BRIEF

published on 01/07/2025 at 12:35, 10 months 29 days ago

Réalisations et perspectives d'avenir d'Immunic en 2024

Essais Cliniques Sclérose En Plaques Immunic SA Vidofludimus Calcique Étapes Clés De 2024
PRESS RELEASE

published on 01/07/2025 at 12:30, 10 months 29 days ago

Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Immunic, Inc. highlights its 2024 accomplishments and upcoming milestones, including positive trial results for vidofludimus calcium in multiple sclerosis. Strengthened team and secured private placement for future growth

Multiple Sclerosis Immunic Vidofludimus Calcium 2024 Accomplishments Upcoming Milestones
BRIEF

published on 11/26/2024 at 12:35, 1 year ago

Immunic, Inc. Set to Participate in December Investor Conference

Investor Conference Immunic, Inc. Vidofludimus Calcium Piper Sandler Small Molecule Therapies
BRIEF

published on 11/26/2024 at 12:35, 1 year ago

Immunic, Inc. s'apprête à participer à la conférence des investisseurs de décembre

Immunic, Inc. Conférence Des Investisseurs Vidofludimus Calcique Piper Sandler Thérapies À Base De Petites Molécules
PRESS RELEASE

published on 11/26/2024 at 12:30, 1 year ago

Immunic, Inc. to Participate in Investor Conference in December
Immunic, Inc. to Participate in Investor Conference in December. Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing therapies for chronic inflammatory and autoimmune diseases, announces participation in Piper Sandler 36th Annual Healthcare Conference in New York

Investor Conference Biotechnology Immunic Inc. Clinical Pipeline Autoimmune Diseases
BRIEF

published on 11/13/2024 at 12:35, 1 year ago

Immunic Publishes Phase 1/1b Trial Data of IMU-856 in The Lancet

Clinical Trial Immunic Gastroenterology IMU-856 Celiac Disease
BRIEF

published on 11/13/2024 at 12:35, 1 year ago

Immunic publie les données de l'essai de phase 1/1b de l'IMU-856 dans The Lancet

Essai Clinique Immunique IMU-856 Maladie Cœliaque Gastroentérologie
PRESS RELEASE

published on 11/13/2024 at 12:30, 1 year ago

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology
Immunic announces publication of phase 1/1b clinical trial data of IMU-856 in The Lancet Gastroenterology & Hepatology. Positive results in celiac disease patients. Potential new approach for gastrointestinal diseases

Gastrointestinal Diseases Clinical Trial Immunic IMU-856 Celiac Disease
BRIEF

published on 11/07/2024 at 12:35, 1 year ago

Immunic, Inc. Reports Q3 2024 Financial Results

Financial Results Vidofludimus Calcium Phase 3 ENSURE Trials Multiple Sclerosis Research Clinical Trial Updates

Accesswire

Published on 12/05/2025 at 15:35, 7 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 17 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 42 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 42 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 42 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:38, 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 12/05/2025 at 15:36, 5 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Published on 12/05/2025 at 15:35, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/05/2025 at 15:33, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/05/2025 at 15:32, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc

Les Echos

Published on 12/05/2025 at 15:10, 31 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 31 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 44 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 57 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 57 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE